Paramit Corporation (Altaris Portfolio Company) Acquires Emphysys, Inc.
November 24, 2020
Paramit Corporation, a portfolio company of Altaris Capital Partners, acquired Emphysys, Inc., a Boston-area technology development firm specializing in medical device, life sciences and industrial product development. The acquisition expands Paramit's upstream product development capabilities and adds a Greater Boston presence to support growth in medical device and life sciences markets.
- Buyers
- Paramit Corporation, Altaris Capital Partners
- Targets
- Emphysys, Inc.
- Platforms
- Paramit Corporation
- Industry
- Medical Devices
- Location
- Massachusetts, United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
The Tecan Group Acquires Paramit from Altaris Capital Partners
June 23, 2021
Medical Devices
The Tecan Group has agreed to acquire Paramit Corporation from Altaris Capital Partners for $1.0 billion, with the transaction expected to close in the third quarter. Paramit, headquartered in Morgan Hill, California, is a contract developer and manufacturer of complex electronic medical devices and life science instruments with ~1,000 employees across the U.S. and Malaysia.
-
Paramit Corporation Acquires S.I.E. SOLUTIONS (System Industrie Electronic GmbH)
October 27, 2020
Medical Devices
Paramit Corporation, a Silicon Valley–based designer and manufacturer of electronics-based medical devices and life science instruments, has agreed to acquire Austrian embedded-systems specialist S.I.E. SOLUTIONS (System Industrie Electronic GmbH) and its German subsidiary. The acquisition establishes Paramit's European headquarters in Lustenau, Austria and is intended to expand Paramit's local manufacturing and development capabilities in Europe; the deal is expected to close in Q4 2020 subject to regulatory approvals.
-
Altaris Capital Partners Acquires Meridian Medical Technologies from Pfizer
December 30, 2021
Medical Devices
Altaris Capital Partners has entered into an agreement to acquire Meridian Medical Technologies from Pfizer. Meridian, a pioneer in emergency response drug-device combination products and auto-injectors with facilities in St. Louis, Missouri and Columbia, Maryland and more than 750 employees, will become an Altaris portfolio company to expand the firm's capabilities in medical countermeasures and emergency response solutions.
-
Ocorian Acquires Emphasys Technologies
March 8, 2021
Financial Services
Ocorian has acquired US-based capital markets service provider Emphasys Technologies, with the agreement reached on 4 March 2021 and completion expected later in March 2021. The deal gives Ocorian a presence in the United States and strengthens its capital markets and technology-enabled service offering to financial institutions.
-
FluidAI Medical Acquires Emmetros Limited (SparxConnect)
November 26, 2025
Healthcare Services
FluidAI Medical acquired Emmetros Limited, the developer of the SparxConnect patient engagement platform, to integrate its capabilities into FluidAI's Stream Inara offering. The deal strengthens FluidAI's RISE surgical recovery suite by expanding patient education, continuous engagement, and post-discharge monitoring to support earlier discharge and improved recovery outcomes.
-
Aptyx Acquires Argos Corporation to Launch Precision Extrusion Center of Excellence
December 5, 2025
Medical Devices
Aptyx has acquired Argos Corporation, a Massachusetts-based precision extrusion specialist, and will establish a Boston-area Precision Extrusion Center of Excellence to expand medical tubing and catheter-grade extrusion capacity. The deal enhances Aptyx’s capabilities for interventional and catheter-based device markets, adding in-house tooling and micro-extrusion expertise to its integrated medical manufacturing platform.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.